Medication info

Diotang Plus Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Valsartan›80mgHydrochlorothiazide›12.5mg
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 200807126 · Notified 2008.06.27

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medicine is used for patients with essential hypertension whose blood pressure is not well controlled with monotherapy. It is effective in aiding blood pressure control and reducing the risk of complications due to hypertension.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious harm or death to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it must be discontinued immediately if pregnancy is confirmed. Individuals who are allergic or hypersensitive to this drug, its ingredients, or sulfonamide drugs should not take it. This medication is not suitable for patients with severe liver disease, severe kidney impairment, or specific kidney diseases and electrolyte imbalances. As this medication lowers blood pressure, it may cause dizziness or symptoms of hypotension, so caution is needed when driving or operating machinery. It may affect potassium levels; therefore, potassium supplements or potassium-rich foods should not be taken excessively without consulting a physician. During the use of this medication, blood pressure, kidney function, and electrolyte levels should be monitored regularly to ensure there are no abnormalities. The hydrochlorothiazide component may cause increased sensitivity to sunlight, thus raising the risk of skin cancer; therefore, it is advisable to avoid sun exposure and take protective measures. Caution should be exercised during this treatment for fluid loss due to dehydration, diarrhea, or vomiting, and if symptoms are severe, consult a physician. Interactions may occur when this drug is taken with certain medications, so inform healthcare personnel if you are taking other medicines, especially with lithium, NSAIDs, or potassium-sparing diuretics. Women who are pregnant or planning to become pregnant, as well as nursing mothers, should refrain from using this medication and consult with healthcare providers if necessary. Special caution is necessary for children and the elderly, as the safety and efficacy of this medication have not been sufficiently established in these populations. Overdose may result in severe hypotension, arrhythmia, electrolyte imbalance, etc.; therefore, the dose must be strictly adhered to, and if any side effects occur, seek immediate medical attention. This medication should be stored in a cool, dry place, away from moisture and direct sunlight, and should be kept out of reach of children, preferably in its original container.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, back pain, cough, upper respiratory tract infection, diarrhea, arthralgia, abdominal pain, upper abdominal pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, shortness of breath, erectile dysfunction, gastroenteritis, hyperhidrosis, loss of sensation, insomnia, hypokalemia, hypotension, influenza, muscle cramps, muscle strain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, pharyngeal pain, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament strain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, anaphylactoid symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, angioedema, rash, vesicular dermatitis, renal failure, hypokalemia, increased blood lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic metabolic alkalosis, hyperglycemia, diabetes mellitus, urticaria, skin rash, photosensitivity reaction, necrotizing vasculitis, erythematous lupus, decreased appetite, nausea, vomiting, abdominal discomfort, constipation, diarrhea, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, loss of sensation, sedation, headache, sleep disorders, depression, paresthesia, visual impairment, leukopenia, bone marrow dysfunction, hemolytic anemia, acute respiratory distress syndrome, erectile dysfunction, hypersensitivity reaction, pneumonia, pulmonary edema, acute closed-angle glaucoma, nausea, drowsiness, hypovolemia, arrhythmia, muscle rigidity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; therefore, it should be stored in an airtight container in a cool place below 30 degrees Celsius. Doing so will help maintain the drug's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.